Articles by Philip M. Schneider - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Philip M. Schneider

Establishing a Minimum Incubation Time for Biological Indicators

The authors propose a minimum incubation-time method that provides a means for reproducible determination of biological indicator grow-out time.
Dec 2, 2013

The industry lacks an accepted method for establishing a minimum incubation time (MIT) of less than seven days for biological indicators (BIs). The authors propose an MIT method that provides a means for reproducible determination of BI grow-out time.

Understanding Biological Indicator Grow-Out Times—Part II

In Part II of a series, the authors report on the range and distribution of grow-out times for biological indicators exposed to sublethal sterilization processes.
Jun 2, 2013

The authors report on the range and distribution of grow-out times for biological indicators exposed to sublethal sterilization processes.

Biological Indicator Growout Times: The Impact on Establishing a Reduced Incubation Time Protocol

The authors provide a review of test methodology and standards, including current industry and regulatory proposals, for biological indicator growout times.
May 1, 2012

The authors provide a review of test methodology and standards, including current industry and regulatory proposals, for biological indicator growout times.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
33%
Breakthrough designations
11%
Protecting the supply chain
39%
Expedited reviews of drug submissions
11%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here